Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Sirijerachai
Event Free Survival at 12 Months and 24 Months as Predictors for Outcome of Systemic Peripheral T Cell Lymphoma: Analysis of Nationwide Thai Lymphoma Study Group
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Progression Free Survival at 12 Months After First-Line Therapy Is Associated With Favourable Outcomes After First Relapse/Progression in Peripheral T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Predictors of Developmental Outcome at 12 Months of <1250 Gram Inborn Neonates
Pediatric Research
Child Health
Pediatrics
Perinatology
Cognitive Impairment After 6 and 12 Months of Hodgkin Lymphoma Treatment
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma
Clinical Case Reports
Medicine
Figure 2: Nomogram for Predicting 6 Months, 12 Months, 18 Months and 24 Months Cancer-Specific Death of VEOPC Patients.
Peripheral T-Cell Lymphoma Mimicking Marginal Zone B-Cell Lymphoma
Modern Pathology
Forensic Medicine
Pathology
Hematopoietic SCT for Peripheral T-Cell Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Outcome of Patients With Relapsed and Refractory Peripheral T Cell Lymphoma Intended for Stem Cell Transplant
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Crescentic Glomerulonephritis Developing 3 Months After Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
